+924.9%
MRNA vs NTRA
+85.0%
+839.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NTRA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | -7.0% | +0.4% | -0.8% |
| 7D | +8.4% | -16.6% | +25.0% | +25.3% |
| 30D | +28.8% | -9.2% | +38.0% | +39.9% |
| 3M | +329.2% | +32.5% | +296.8% | +271.8% |
| 6M | +416.9% | +75.9% | +341.0% | +304.3% |
| YTD | +718.8% | +58.8% | +660.0% | +584.0% |
| 1Y | +924.9% | +82.0% | +842.9% | +704.4% |
| All | +924.9% | +85.0% | +839.9% | +704.4% |
Cumulative growth
Daily Returns
Daily percentage return beside NTRA.
Daily Out/Under-Performance
Portfolio return minus NTRA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTRA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NTRA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling